Clinical Trial Update: Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT) [NA]

View source ↗

Summary

The University of Zurich completed a study evaluating 6-minute walk distance in individuals with High Altitude Pulmonary Hypertension at 3200 m, comparing outco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High Altitude Pulmonary Hypertension

Snippet

Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED